Profitelligence Profitelligence · Filing Ledger Open DHR research →

Form 8-K · Current Report · Filed 2024-12-11

Danaher Corporation Announces Retirement of Board Member Pardis C. Sabeti

On December 9, 2024, Danaher Corporation announced the retirement of Board Member Pardis C.

Filer
Danaher Corporation DHR · NYSE
Filed
Accession
0000313616-24-000251
CIK
0000313616
Signal
Medium impactHealthcare

Details

Sabeti, effective December 10, 2024. The decision was due to her time commitments related to other professional obligations, and there were no disagreements with the company regarding operations, policies, or practices. The retirement does not impact the company's ongoing business activities.

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

Board Member Departure
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$234.34

Next session

+0.1%

Since filing

-16.8%

Latest close

$194.98

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from DHR reporting the same item, with the next session's move:

About Danaher Corporation

Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another DHR filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts